Association of apo B lipoproteins with arterial proteoglycans: Pathological significance and molecular basis

Atherosclerosis

Volumn 139, Issue 2, 1998, Pages 205-222

  Camejo, Germán ^a,b   Hurt Camejo, Eva ^b   Wiklund, Olov ^b   Bondjers, Göran ^b  

^a ASTRAZENECA R AND D   (Sweden)

^b UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

Cardiovascular disease; Intima proteoglycans; Lipoprotein modification; Low density lipoprotein affinity for proteoglycans; Macrophages; Small dense low density lipoproteins

Indexed keywords

APOLIPOPROTEIN B; CHONDROITIN SULFATE; DERMATAN SULFATE; GLYCOSAMINOGLYCAN; LIPOPROTEIN A; LOW DENSITY LIPOPROTEIN; PROTEOGLYCAN;

ARTERY INTIMA; ATHEROGENESIS; CARDIOVASCULAR DISEASE; COMPLEX FORMATION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; LIPOPROTEIN METABOLISM; MACROPHAGE ACTIVATION; PRIORITY JOURNAL; PROTEIN LIPID INTERACTION; RECEPTOR AFFINITY; REVIEW; SMOOTH MUSCLE FIBER;

EID: 0031877416     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(98)00107-5     Document Type: Article

References (131)

1. McGill HC. Major risk factors and primary prevention. In: Fuster V, Ross R, Topol E, editors. Atherosclerosis and Coronary Heart Disease. Philadelphia: Lippincott-Raven, 1996;1:25-41.
2. Group SSSS. Randomized trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet 1994;344:1383-1389.
3. Shepherd J, Cobbe S, Ford I, Isles C, Lorimer R, MacFarlane P, McKillop J, Packard C Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. New Engl J Med. 333:1995;1301-1307.
4. Smith EB, Slater RS Relationship between low density lipoprotein in aortic intima and serum lipid levels. Lancet. 1:1972;463-469.
5. Smith EB, Staples EM Distribution of plasma proteins across the human aortic wall: Barrier functions and endothelium and internal elastic lamina. Atherosclerosis. 37:1980;579-590.
6. Camejo G The interaction of lipids and lipoproteins with the intercellular matrix of arterial tissue: Its possible role in atherogenesis. Adv Lipid Res. 19:1982;1-54.
7. Small DM Progression and regression of atherosclerotic lesions: insights from lipid physical biochemistry. Arteriosclerosis. 8:1988;103-129.
8. Camejo G, Hurt E, Wiklund O, Rosengren B, López F, Bondjers G Modifications of low density lipoprotein induced by arterial proteoglycans and chondroitin-6-sulfate. Biochim Biophys Acta. 1096:1991;253-261.
9. Gayton J, Klemp K Development of the lipid-rich core in human atherosclerosis. Atheroscler Thromb Vasc Biol. 16:1996;4-11.
10. 2-modified LDL is taken up at enhanced rate by macrophages. Biochem Biophys Res Commun. 185:1992;465-472.
11. Tabas I, Yueqing L, Brocia R, Xu S, Swenson T Lipoprotein lipase and sphingomyelinase synergistically enhance the association of atherogenic lipoproteins with smooth muscle cells and extracellular matrix. J Biol Chem. 268:1993;20419-20432.
12. Hurt-Camejo E, Andersen S, Sandal R, Rosengren B, Sartipy P, Stadberg E, Johansen B Localization of non pancreatic secretory phospholipase A2 in normal and atherosclerotic arteries: activity of the isolated enzyme on low density lipoproteins. Arterioscler Thromb Vasc Biol. 17:1997;300-309.
13. Hurt-Camejo E, Camejo G Potential involvement of type II phospholipase A2 in atherosclerosis. Atherosclerosis. 132:1997;1-8.
14. Navab M, Berliner J, Watson A, Hama S, Territo M, Lusis A, Shih D, Van Lenten B, Frank J, Demer L, Edwards P, Fogelman A The Yin and Yang of oxidation in the development of the fatty streak. Arterioscler Thromb Vasc Biol. 16:1996;831-842.
15. Williams KJ, Tabas I The response-to-retention hypothesis of early atherogenesis. Arterioscler Thromb Vasc Biol. 15:1995;551-561.
16. Katz SS The lipids of grossly normal human aortic intima from birth to old age. J Biol Chem. 256:1981;12275-12280.
17. Smith EB, Slater R. Lipids and low density lipoproteins in intima in relation to its morphological characteristics. In: Atherogenesis Initiating Factors. Cyba Symposium 12, Vol. 12. Amsterdam: Elsevier, 1973:39-62.
18. Schwenke DC, Carew TE Initiation of atherosclerotic lesions in cholesterol-fed rabbits. I. Focal increases in arterial LDL concentrations precede development of fatty streak lesions. Arteriosclerosis. 9:1989;895-907.
19. Schwenke DC, Carew TE Initiation of atherosclerotic lesions in cholesterol-fed rabbits. II. Selective retention of LDL versus selective increases in LDL permeability in susceptible sites of arteries. Arteriosclerosis. 9:1989;908-918.
20. Schwenke D Selective increase in cholesterol at atherosclerosis-susceptible aortic sites after short-term cholesterol feeding. Arterioscler Thromb Vasc Biol. 15:1995;1928-1937.
21. Björnheden T, Babyi A, Bondjers G, Wiklund O Accumulation of lipoprotein fractions and subfractions in the arterial wall, determined in an in vitro perfusion system. Atherosclerosis. 123:1996;43-56.
22. Nielsen L, Stender S, Jauhianien M, Nordestgaard B Preferential influx and decreased fractional loss of lipoprotein(a) in atherosclerosis compared with non-lesioned rabbit aorta. J Clin Invest. 98:1996;563-571.
23. Collins E, Carew T Residence time of low-density lipoprotein in the normal and atherosclerotic rabbit aorta. Circ Res. 80:1997;208-218.
24. 125I-tyramine cellobiose-LDL in atherosclerotic lesions of the WHHL rabbit. Arterioscler Thromb. 12:1992;985-995.
25. Fogelman AM, Van Lenten B, Warden C, Haberland M, Edwards P Macrophage lipoprotein receptors. J Cell Sci. Suppl 9:1988;135-149.
26. Jackson RL, Busch SJ, Cardin AD Glycosaminoglycans: molecular properties, protein interactions and role in physiological processes. Physiol Rev. 71:1991;481-539.
27. Camejo G, Hurt-Camejo E, Olsson U, Rosengren B, Bondjers G. Interactions of low density lipoproteins with proteoglycans: Molecular basis and consequences. In: Wooford FP, Davignon J, Sniderman A, editors. Atherosclerosis X. Amsterdam: Elsevier, 1995:365-368.
28. Wight TN. The Vascular Extracellular Matrix. In: Fuster V, Ross R, Topol E, editors. Atherosclerosis and Coronary Artery Disease. Philadelphia: Lippincott-Raven, 1996;1:421-440.
29. Stary HC, Blakenhorn D, Chandler A, Glagov S, Insull W, Richardson M, Rosenfeld M, Schaffer S, Schwartz C, Wagner WRW A definition of the intima of human arteries and its atherosclerosis-prone regions. Circulation. 85:1992;391-405.
30. Nievelstein P, Fogelman A, Mottino G, Frank J Lipid accumulation in rabbit aortic intima 2 hours after bolus infusion of low density lipoprotein: A deep-etch and immunolocalization study of ultrarapidly frozen tissue. Arterioscler Thromb. 11:1991;1795-1805.
31. Nievelstein-Post P, Mottino G, Fogelman A, Frank J An ultrastructural study of lipoprotein accumulation in cardiac valves of the rabbit. Arterioscler Thromb. 14:1994;1151-1161.
32. Comper W Physiological functions of connective tissue polysaccharides. Physiol Rev. 58:1978;255-315.
33. Radhakrishnamurthy B, Srinivasan S, Vijayagopal P, Berenson G Arterial wall proteoglycans: biological properties related to pathogenesis of atherosclerosis. Eur Heart J. 11(Suppl E):1990;148-157.
34. Völker W, Schmidt A, Buddecke E Cytochemical changes in a human arterial proteoglycan related to atherosclerosis. Atherosclerosis. 77:1989;117-130.
35. Wagner WD, Salisbury BG, Rowe HA A proposed structure of chondroitin 6-sulfate proteoglycans of human normal and adjacent atherosclerotic plaque. Arteriosclerosis. 6:1988;407-417.
36. Alavi M, Richardson M, Moore S The in vivo interactions between serum lipoproteins and proteoglycans of the neointima of rabbit aorta after a single balloon catheter injury. Am J Pathol. 134:1989;287-294.
37. Steele R, Wagner W Lipoprotein interaction with artery wall derived proteoglycan. Comparisons between atherosclerosis-susceptible WC-2 and resistant Show Racer pigeons. Atherosclerosis. 65:1987;63-73.
38. Camejo G, Olofsson S-O, López F, Carlsson P, Bondjers G Identification of apoB-100 segments mediating the interaction of low density lipoproteins with arterial proteoglycans. Arteriosclerosis. 8:1988;368-377.
39. Srinivasan SR, Dolan P, Radhakrishnamurthy B, Pargaonkar PS, Berenson GS Lipoprotein mucopolysaccharide complexes from human atherosclerotic lesions. Biochim Biophys Acta. 388:1975;58-70.
40. Srinivasan S, Yost C, Bandarhu R, Radahkrisnamurthy BGB Lipoprotein-glycosaminoglycans interactions in aortas of rabbits fed atherogenic diets containing different fats. Atherosclerosis. 43:1982;289-301.
41. Camejo G, Hurt E, Romano M Properties of lipoprotein complexes isolated by affinity chromatography from human aorta. Biomed Biophys Acta. 44:1985;389-401.
42. Vijayagopal P, Srinivasan SR, Radhakrishnamurthy B, Berenson GS Lipoprotein-proteoglycan complexes from atherosclerotic lesions promote cholesteryl ester accumulation in human monocytes/macrophages. Arterioscler Thromb. 12:1992;237-249.
43. Galis Z, Alavi M, Moore S Co-localization of aortic apolipoprotein B and chondroitin sulfate in an injury model of atherosclerosis. Am J Pathol. 142:1993;1432-1438.
44. Pentikäinen M, Öörni K, Lassila R, Kovanen P The proteoglycan decorin links low density lipoproteins collagen type I. J Biol Chem. 272:1997;7633-7638.
45. Olin K, Chait A, Wight T Lipoprotein lipase enhances the binding of native and oxidized low density lipoproteins to biglycan and versican. Circulation. 96(Suppl):1997;I-40.
46. Bourin M-C, Lindahl U Glycosaminoglycans and the regulation of blood coagulation. Biochem J. 289:1993;313-330.
47. Rosenberg B, Schworak N, Liu J, Schwartz J, Zhang L Heparan sulfate proteoglycans of the cardiovascular system: specific structures emerge but how is synthesis regulated? J Clin Invest. 100:1997;S67-S75.
48. Olsson U, Camejo G, Hurt-Camejo E, Elfsber K, Wiklund O, Bondjers G Possible functional interactions of apolipoprotein B-100 segments that associate with cell proteoglycans and the apoB/E receptor. Arterioscler Thromb Vasc Biol. 17:1997;149-155.
49. Fuki I, Kuhn K, Lomazov I, Rothman V, Tuzynsky G, Iozzo R, Swenson T, Fisher E, Williams K The syndecan family of proteoglycans: novel receptors mediating internalization of atherogenic lipoproteins in vitro. J Clin Invest. 100:1997;1611-1622.
50. Eisenberg S, Sehayek E, Olivecrona T, Vlodavsky I Lipoprotein lipase enhances binding of lipoproteins to heparan sulfate on cell surfaces and extracellular matrix. J Clin Invest. 90:1992;2013-2021.
51. Saxena U, Auerbach BEF, Wölle J, Marcel Y, Weisgraber KH, Hegele R, Bisgaier C Apolipoprotein B and E basic aminoacid clusters influence low density lipoprotein lipase anchored to the subendothelial matrix. Arterioscler Thromb Vasc Biol. 15:1995;1240-1247.
52. Goldberg I Lipoprotein lipase and lipolysis: central roles in lipoprotein metabolism and atherogenesis. J Lipid Res. 37:1996;693-707.
53. Zilversmit D Atherogenesis a postprandial phenomenon. Circulation. 60:1979;473-485.
54. Walton K, Williamson N Histological and immunofluorescent studies on the evolution of the human atheromatous plaque. J Atheroscler Res. 8:1968;599-624.
55. Hoff H, Bond G Apolipoprotein B localization in coronary atherosclerotic plaques from cynomolgus monkeys. Artery. 12:1983;104-116.
56. Hoff H, Wagner W Plasma low density lipoprotein accumulation in aortas of hypercholesterolemic swine correlates with modification of aortic glycosaminoglycan composition. Atherosclerosis. 61:1986;231-236.
57. Camejo G, Fager G, Rosengren B, Camejo-Hurt E, Bondjers G Binding of low density lipoproteins by proteoglycans synthesized by proliferating and quiescent human arterial smooth muscle cells. J Biol Chem. 268:1993;14131-14137.
58. Faber M The human aorta: Sulfate-containing polyuronides and the deposition of cholesterol. Arch Pathol Lab Med. 48:1949;342-350.
59. Gero S, Gergely J, Szérely L, Virag S Role of mucoid substances of the aorta in the deposition of lipids. Nature. 187:1960;152-153.
60. Hollander W Unified concept on the role of acidic mucopolysaccharides and connective tissue proteins in the accumulation of lipids lipoproteins and calcium in the atherosclerotic plaque. Exp Mol Pathol. 25:1976;106-120.
61. Camejo G, Waich S, Quintero G, Berrizbeitia ML, LaLaguna F The affinity of low density lipoproteins for an arterial macromolecular complex: A study in ischemic heart disease and controls. Atherosclerosis. 24:1976;341-354.
62. Bruce R Progress in exercise electrocardiography. Prog Cardiol. 3:1974;113-122.
63. Lindén T, Bondjers G, Camejo G, Bergstrand R, Wilhelmsen L, Wiklund O Affinity of LDL to a human arterial proteoglycan among male survivors of myocardial infarction. Eur J Clin Invest. 19:1989;38-44.
64. Anber V, Griffin B, McConnell M, Packard C, Sheperd J Influence of plasma lipid and LDL-subfraction profile on the interaction between low density lipoprotein with human arterial wall proteoglycans. Atherosclerosis. 124:1996;261-271.
65. Austin MA, King MC, Vranizan KM, Krauss RM Atherogenic lipoprotein phenotype A. A proposed genetic marker for coronary heart disease. Circulation. 82:1990;495-506.
66. Krauss RM Genetic, metabolic, and dietary influences on the atherogenic lipoprotein phenotype. World Rev Nutr Diet. 80:1997;22-43.
67. Lindgren F. Historical perspective on lipoprotein research and methodology. In: Perking EG, editor. Analysis of Fats, Oils and Lipoproteins. Champaign: American Oil Chemists' Society, 1991:496-511.
68. Anber V, Millar J, McConnell M, Sheperd J, Packard C Interaction of very-low-density, and low density lipoproteins with human arterial proteoglycans. Arterioscler Thromb Vasc Biol. 17:1997;2507-2514.
69. Camejo G, Waich S, Mateu L, Acquatella H, LaLaguna F, Quintero G, Berrizbeitia ML Differences in the structure of plasma low density lipoproteins and their relationship to the extent of interaction with arterial wall components. Ann New York Acad Sci. 275:1976;153-168.
70. Avila EM, López F, Camejo G Properties of low density lipoproteins related to its interaction with arterial wall components: in vitro and in vivo studies. Artery. 4:1978;36-60.
71. Camejo G, López A, López F, Quiñones J Interaction of low density lipoproteins with arterial proteoglycans: the role of charge and sialic acid content. Atherosclerosis. 55:1985;93-105.
72. Camejo G, Linden T, Olsson U, Wiklund O, Lopéz F, Bondjers G Binding parameters and concentration modulate formation of complexes between LDL and arterial proteoglycans in serum. Atherosclerosis. 79:1989;121-128.
73. Hurt-Camejo E, Camejo G, Rosengren B, López F, Wiklund O, Bondjers G Differential uptake of proteoglycan-selected subfractions of low density lipoprotein by human macrophages. J Lipid Res. 31:1990;1387-1398.
74. Hauton JC, Lafont H Lipid biodynamics: new perspectives. Biochimie. 69:1987;117-204.
75. McNamara J, Small D, Li Z, Schaefer E Differences in LDL subspecies involve alterations in lipid composition and conformational changes in apolipoprotein B. J Lipid Res. 37:1996;1924-1935.
76. Tilly-Kiesi M, Knudsen P, Groop L, Taskinen M-R, Nissen M, Forsen B Hyperinsulinemia and insulin resistance are associated with multiple abnormalities of lipoprotein subclasses in glucose-tolerant relatives of NIDDM patients. J Lipid Res. 37:1996;1569-1578.
77. Laakso M, Lehto S Epidemiology of macrovascular disease in diabetes. Diabetes Rev. 5:1997;294-315.
78. Bernfeld P, Nisselbaum J Reaction of human betalipoglobulin with macromolecular polysulfated esters. Fed Proc. 15:1956;220-227.
79. Bihari-Varga M, Vegh M Quantitative studies on the complexes formed between aortic mucopolysaccharides and serum lipoproteins. Biochim Biophys Acta. 144:1967;202-210.
80. Gelman RA, Glaser DN, Blackwell J Interaction between chondroitin-6-sulfate and poly-L-arginine in aqueous solution. Biopolymers. 12(6):1973;1223-1232.
81. Iverius P-H The interaction between human plasma lipoproteins and connective tissue glycosaminoglycans. J Biol Chem. 247:1972;2607-2613.
82. Chen S-H, Yang C-H, Chen P-F, Tanimura M, Li W-H, Gotto A, Chan L The complete cDNA and aminosequence of human apolipoprotein B-100. J Biol Chem. 261:1986;12918-12921.
83. Hirose N, Blankenship DT, Krivanek MA, Jackson RL, Cardin AD Isolation and characterization of four heparin-binding cyanogen bromide peptides of human plasma apolipoprotein B. Biochemistry. 26(17):1987;5505-5512.
84. Camejo G, Rosengren B, Olsson U, López Olofsson S-O, Westerlund C, Bondjers G Molecular basis of the association of arterial proteoglycans with low density lipoproteins: Its effect on the structure of the lipoprotein particle. Eur Heart J. 11(Suppl E):1990;164-173.
85. Olsson U, Camejo G, Olofsson S-O, Bondjers G Molecular parameters that control the association of low density lipoprotein apoB-100 with chondroitin sulphate. Biochim Biophys Acta. 1097:1991;37-44.
86. Olsson U, Camejo G, Bondjers G Binding of a synthetic apolipoprotein B-100 peptide and peptide analogues to chondroitin 6-sulfate: effects of the lipid environment. Biochemistry. 32(7):1993;1858-1865.
87. Wiklund O, Matsson L, López F, Bondjers G Cationic polypeptides modulate in vitro the association of low density lipoproteins with arterial proteoglycans, fibroblasts and arterial tissue. Arteriosclerosis. 10:1990;695-702.
88. Chan L Apolipoprotein B, the major protein component of triglyceride-rich and low density lipoproteins. J Biol Chem. 267:1992;25621-25624.
89. Young SG Recent progress in understanding apolipoprotein B. Circulation. 82:1990;1574-1594.
90. Dyer CA, Curtiss LK A synthetic peptide mimic of plasma apolipoprotein E that binds the LDL receptor. J Biol Chem. 266(34):1991;22803-22806.
91. Chatterton J, Phillips M, Curtiss LK, Milne R, Fruchart J-C, Schumaker V Immunoelectron microscopy of low density lipoproteins yields a ribbon and bow model for the conformation of apolipoprotein B on the lipoprotein surface. J Lipid Res. 36:1995;2027-2037.
92. Segrest J, Jones M, Mishra V, Anantharamaiah G, Garber D Apo B-100 has a pentapartite structure composed of three amphipathic α-helical domains alternating with two amphipathic β-strands domain: detection by the computer program domain. Arterioscler Thromb Vasc Biol. 14:1994;1674-1685.
93. Segrest J, Jones M, Mishra V, Pierotti V, Young S, Borén J, Innerarity T, Dashti N Apolipoprotein B-100: conservation of lipid-associating amphipathic secondary structural motifs in nine species of vertebrates. J Lipid Res. 39:1998;85-102.
94. Hurt-Camejo E, Olsson U, Wiklund O, Bondjers G, Camejo G Cellular consequences of the association of apoB lipoproteins with proteoglycans: potential contribution to atherogenesis. Arterioscler Thromb Vasc Biol. 17:1997;1011-1017.
95. Borén J, Lee I, Zhu W, Arnold K, Taylor S, Innerarity T Identification of the low density lipoprotein receptor-binding site in apolipoprotein B100 and the modulation of its binding activity by the carboxyl terminus in familial defective apo-B-100. J Clin Invest. 101:1998;1084-1093.
96. Mascotti DP, Lohman TM Thermodynamics of charged oligopeptide heparin interactions. Biochemistry. 34(9):1995;2908-2915.
97. Pantoliano MWRH, Springer B, Van Dyk D, Tobery T, Wetmore DR, Lear J, Nahapetian A, Bradley J, Sisk J Multivalent ligand-receptor binding interactions in the fibroblast growth system produce a cooperative growth factor and heparin mechanism for receptor dimerization. Biochemistry. 33:1994;10229-10248.
98. Mateu L, Avila EM, León V, Liscano N The structural stability of low density lipoprotein: a kinetic X-ray scattering study of its interaction with arterial wall proteoglycans. Biochim Biophys Acta. 795:1984;525-534.
99. Daugherty A, Zweifel BS, Sobel BE, Schonfeld G Isolation of low density lipoprotein from atherosclerotic vascular tissue of Watanabe heritable hyperlipidemic rabbits. Arteriosclerosis. 8:1988;768-777.
100. Tailleux A, Torpier G, Caron B, Fruchart J-C, Fievet C Immunological properties of apoB-containing lipoprotein particles in human atherosclerotic arteries. J Lipid Res. 34:1993;719-728.
101. Sartipy P, Johansen B, Camejo G, Rosengren B, Bondjers G, Hurt-Camejo E Binding of human phospholipase A2 type II to proteoglycans: Differential effect of glycosaminoglycans on enzyme activity. J Biol Chem. 42:1996;26307-26314.
102. Kume N, Cybulsky MI, Gimbrone MA Lysophosphatidylcholine, a component of atherogenic lipoproteins, induces mononuclear leukocyte adhesion molecules in cultured human and rabbit arterial endothelial cells. J Clin Invest. 90:1992;1138-1144.
103. Kume N, Gimbrone MA Lysophosphatidylcholine transcriptionally induces growth factor gene expression in cultured human endothelial cells. J Clin Invest. 93:1994;907-911.
104. Hirata K-I, Miki N, Kuroda Y, Sakoda T, Kawashima S, Yokoyama M Low concentration of oxidized low-density lipoprotein and lysophosphatidylcholine upregulate constitutive nitric oxide synthase mRNA expression in bovine aortic endothelial cells. Circ Res. 76:1995;958-962.
105. Chai Y, Howe P, DiCorleto P, Chisolm G Oxidized low density lipoprotein and lysophosphatidylcholine stimulate cell cycle entry in vascular smooth muscle cell. J Biol Chem. 271:1996;1791-1797.
106. Schissel S, Tweedie-Hardman J, Rapp J, Graham G, Williams K, Tabas I Rabbit aorta and human atherosclerotic lesions hydrolyze the sphingomyelin of retained low-density lipoprotein. J Clin Invest. 98:1996;1455-1464.
107. Schissell S, Jiang X-C, Tweedie-Hardman J, Jeong T-S, Hurt-Camejo E, Najib J, Rapp J, Williams K, Tabas I Secretory sphingomyelinase, a product of the acid sphingomyelinase gene, can hydrolyze atherogenic lipoproteins at neutral pH. J Biol Chem. 273:1998;2738-2746.
108. Camejo G, Hurt-Camejo E, Rosengren B, Wiklund O, López F, Bondjers G Modification of copper-catalyzed oxidation of low density lipoprotein by proteoglycans and glycosaminoglycans. J Lipid Res. 32:1991;1983-1991.
109. Hurt-Camejo E, Camejo G, Rosengren B, López FCA, Fager G, Bondjers G Effect of arterial proteoglycans and glycosaminoglycans on low density lipoprotein oxidation and its uptake by human macrophages and arterial smooth muscle cells. Arterioscler Thromb. 12:1992;569-583.
110. Sutherland WH Oxidation of heparin isolated LDL by hemin: the effect of serum components. Arterioscler Thromb. 14:1994;1966-1975.
111. Hoff HF, Gaubatz JW Isolation, purification and characterization of a lipoprotein containing apo B from the human aorta. Atherosclerosis. 42:1982;273-297.
112. Hoff H, O'Neil J Lesion-derived low density lipoprotein and oxidized low density lipoprotein share a lability for aggregation leading to enhanced macrophage degradation. Arterioscler Thromb. 11:1991;1209-1222.
113. Amenta J, Waters L The precipitation of serum lipoproteins by mucopolysaccharides extracted from aortic tissue. Yale J Biol Med. 33:1960;112-121.
114. Iverius P-H. Possible role of the glycosaminoglycans in the genesis of atherosclerosis. In: Porter R, Knight J, editors. Atherogenesis: Initiating Factors. Ciba Foundation Symposium, Vol 12. Amsterdam: Elsevier, 1973:185-196.
115. Steele R, Wagner W, Rowe H, Edwards I Artery wall derived proteoglycan-plasma lipoprotein interactions: lipoprotein-binding properties of extracted laboratories. Atherosclerosis. 65:1987;51-62.
116. Hollmann J, Thiel J, Schmidt A, Buddecke E Increased activity of chondroitin sulfate-synthesizing enzymes during proliferation of arterial smooth muscle cells. Exp Cell Res. 167:1986;484-494.
117. Merriles MJ, Campbell JH, Spanidis E, Campbell GR Glycosaminoglycan synthesis by smooth muscle cells of differing phenotype and their response to endothelial cell conditioned media. Atherosclerosis. 81:1990;245-254.
118. Schmidt A, Buddecke E Changes in heparan sulfate structure during transition from the proliferating to the non-dividing state of cultured arterial smooth muscle cell. Eur J Cell Biol. 52:1990;229-235.
119. Schönherr E, Järveläinen HT, Sandell LJ, Wight TN Effects of platelet-derived growth factor and transforming growth factor β1 on the synthesis of large versican-like chondroitin sulfate proteoglycan by arterial smooth muscle cell. J Biol Chem. 266:1991;17640-17647.
120. Cardoso LE, Mourao PA Glycosaminoglycan fractions from human arteries presenting diverse susceptibilities to atherosclerosis have different binding affinities to plasma LDL. Arterioscler Thromb. 14:1994;115-124.
121. Edwards IJ, Xu H, Obunike J, Goldberg I, Wagner WD Differentiated macrophages synthesize a heparan sulfate proteoglycan and an oversulfated chondroitin sulfate proteoglycan that bind lipoprotein lipase. Arterioscler Thromb Vasc Biol. 15:1995;400-409.
122. Hurt E, Bondjers G, Camejo G Interaction of LDL with human arterial proteoglycans stimulates its uptake by human monocyte-derived macrophages. J Lipid Res. 31:1990;443-454.
123. Hurt E, Camejo G Effect of arterial proteoglycans on the interaction of LDL with human monocyte-derived macrophages. Atherosclerosis. 67:1987;115-126.
124. Vijayagopal P, Srinivasan SR, Xu J-H, Dalfere ED, Radhakrishnamurthy B, Berenson GS Lipoprotein-proteoglycan complexes induce continued cholesteryl ester accumulation in foam cells from rabbit atherosclerotic lesions. J Clin Invest. 91:1993;1011-1018.
125. Vijayagopal P, Glancy L Macrophages stimulate cholesteryl ester accumulation in cocultured smooth muscle cells incubated with lipoprotein-proteoglycan complex. Arterioscler Thromb Vasc Biol. 16:1996;1112-1121.
126. Kovanen PT Mast cell granule-mediated uptake of low density lipoproteins by macrophages: A novel carrier mechanisms leading to formation of mast cells. Ann Med. 23:1991;551-559.
127. Wang Y, Lindstedt K, Kovanen P Mast cells granule remnants carry LDL into smooth muscle cells of the synthetic phenotype and induce their conversion into foam cells. Arterioscler Thromb Vasc Biol. 15:1995;801-810.
128. Manning J, Gebre A, Edwards A, Wagner W, Rudel L Dietary polyunsaturated fat decreases interactions between low density lipoproteins and arterial proteoglycans. Lipids. 29:1994;635-641.
129. Carmena R, Ascaso J, Camejo G, Varela G, Hurt-Camejo E, Ordovas J, Martinez-Valls J, Bergström M, Wallin B Effect of olive and sunflower oils on low density lipoprotein level, composition, size, oxidation and interaction with arterial proteoglycans. Atherosclerosis. 125:1996;243-256.
130. Fagerberg B, Wiklund O, Agewall S, Camejo G, Wikstrand RJ Multifactorial treatment of hypertensive men at high cardiovascular risk and low-density lipoprotein cholesterol affinity to human arterial proteoglycans. Eur J Clin Invest. 26:1996;960-965.
131. Wiklund O, Bondjers G, Wright I, Camejo G Insoluble complex formation between LDL and arterial proteoglycans in relation to serum lipid levels and effect of lipid lowering drugs. Atherosclerosis. 119:1996;57-68.